Modifications

8 octets ajoutés ,  9 décembre 2018 à 14:53
Ligne 11 : Ligne 11 :  
== Sur le forum de LymeNet Europe en 2011 à propos de QMedRx ==
 
== Sur le forum de LymeNet Europe en 2011 à propos de QMedRx ==
 
=== L'étude de [[Raphael Stricker]] de 2011 ===
 
=== L'étude de [[Raphael Stricker]] de 2011 ===
Tout d'abord, les blogeurs discutent d'une étude "''Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease''" de [[Raphael Stricker]] <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177589/ Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Published online 2011 Sep 6</ref>
+
Tout d'abord, les membres du forum discutent d'une étude "''Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease''" de [[Raphael Stricker]] <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177589/ Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Published online 2011 Sep 6</ref>
    
Note what organisations the authors of the study are associated with:
 
Note what organisations the authors of the study are associated with:
6 958

modifications